SH

Sanjay Haribhau Dhurjad

Director DIN 01829344
DIN 01829344 First appointment Feb 2005
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Feb 2005
Shareholding value β€’β€’β€’β€’ Premium profile

About Sanjay Haribhau Dhurjad

Data last updated:

Sanjay Haribhau Dhurjad was a Director at Sushrusha Hospitals Private Limited (from 2005) and Managing Director at Siscon Pharmaceuticals Manufacturing Private Limited (from 2005).

DIN 01829344
First Appointment 14 Feb 2005
Oldest Company Age 21 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sushrusha Hospitals Private Limited U85100MH2005PTC152431
Director05 Apr 20052005Strike Off
Managing Director14 Feb 20052005Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sushrusha Hospitals Private Limited
Siscon Pharmaceuticals Manufacturing Private Limited
Premium access

Shareholding and investment profile for Sanjay Haribhau Dhurjad

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanjay Haribhau Dhurjad

Sanjay Haribhau Dhurjad was first appointed on 14 Feb 2005 as Managing Director at Siscon Pharmaceuticals Manufacturing Private Limited.

Sanjay Haribhau Dhurjad held 2 earlier board appointments: Sushrusha Hospitals Private Limited (Director, from 05 Apr 2005); Siscon Pharmaceuticals Manufacturing Private Limited (Managing Director, from 14 Feb 2005).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available